Ripasudil Hydrochloride Hydrate in the Treatment of Glaucoma: Safety, Efficacy, and Patient Selection

Reduction of intraocular pressure (IOP) is the only reliable treatment for glaucoma that maintains the patient’s visual function throughout life, and IOP-lowering eyedrops are the mainstay of therapy. Ripasudil hydrochloride hydrate (brand name: Glanatec ophthalmic solution 0.4%; Kowa Company, Ltd.,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kusuhara, Sentaro, Nakamura, Makoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212985/
https://www.ncbi.nlm.nih.gov/pubmed/32440089
http://dx.doi.org/10.2147/OPTH.S216907

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212985/
https://www.ncbi.nlm.nih.gov/pubmed/32440089
http://dx.doi.org/10.2147/OPTH.S216907

Ejemplares similares